30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Zevra Therapeutics Inc (ZVRA)

Track

Over the last 90 days, Zevra Therapeutics Inc. has seen significant insider selling activity, totaling $863,162.54 across three transactions. Notably, executives like the Chief Legal & Compliance Officer and the President and CEO have been involved in planned and proposed sales. This activity occurred against a backdrop of strong stock performance, with the price increasing by 38.3% in the past 90 days.
Stock chart
Ticker: ZVRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Thompson Rahsaan
Chief Legal & Compliance
1 sale — total 100,000 USD
Planned sale 22 Jun 2026
Value US$4,793,621.10 | Price 442.54 | Shares 25,302
Planned sale 11 May 2026
Value US$3,062,125.63 | Price 346.28 | Shares 90,919
Proposed sale 11 May 2026
Value US$404,586.63 | Price 11.13 | Shares 36,351
Proposed sale 16 Mar 2026
Value US$3,409,374.36 | Price 9.87 | Shares 345,428
Planned sale 9 Feb 2026
Value US$125,185.61 | Price 8.56 | Shares 14,625
Planned sale 3 Feb 2026
Value US$27,548.10 | Price 9.18 | Shares 3,000
Planned sale 3 Feb 2026
Value US$96,500.25 | Price 9.19 | Shares 10,500
Proposed sale 2 Feb 2026
Value US$950,625.00 | Price 9.00 | Shares 105,625
Planned sale 2 Feb 2026
Value US$853,425.30 | Price 9.38 | Shares 91,000
Planned sale 30 Jan 2026
Value US$36,009.67 | Price 8.83 | Shares 4,080
Planned sale 30 Jan 2026
Value US$15,442.00 | Price 8.82 | Shares 1,750
Planned sale 30 Jan 2026
Value US$29,800.24 | Price 8.83 | Shares 3,375
Planned sale 30 Jan 2026
Value US$40,035.91 | Price 8.83 | Shares 4,533
Proposed sale 30 Jan 2026
Value US$42,085.00 | Price 8.86 | Shares 4,750
Proposed sale 30 Jan 2026
Value US$124,040.00 | Price 8.86 | Shares 14,000
Proposed sale 30 Jan 2026
Value US$36,148.80 | Price 8.86 | Shares 4,080
Proposed sale 30 Jan 2026
Value US$122,932.50 | Price 8.86 | Shares 13,875
Proposed sale 30 Jan 2026
Value US$40,162.38 | Price 8.86 | Shares 4,533
Proposed sale 10 Oct 2025
Value US$210,990.00 | Price 10.82 | Shares 19,500
Planned sale 10 Oct 2025
Value US$210,908.10 | Price 10.82 | Shares 19,500
Buy 12 Sep 2025
Value US$24,718.01 | Price 7.79 | Shares 3,175
Buy 12 Sep 2025
Value US$157,800.00 | Price 7.89 | Shares 20,000
Buy 19 Aug 2025
Value US$45,825.00 | Price 9.17 | Shares 5,000
Planned sale 26 Jun 2025
Value US$221,004.00 | Price 9.21 | Shares 24,000
Proposed sale 26 Jun 2025
Value US$223,920.00 | Price 9.33 | Shares 24,000
Buy 28 Mar 2025
Value US$2,351.52 | Price 7.84 | Shares 300
Buy 19 Mar 2025
Value US$79,624.00 | Price 7.96 | Shares 10,000
Planned sale 14 Feb 2025
Value US$245,961.67 | Price 8.05 | Shares 30,544
Planned sale 13 Feb 2025
Value US$23,587.80 | Price 7.86 | Shares 3,000
Planned sale 13 Feb 2025
Value US$481,428.09 | Price 7.86 | Shares 61,273
Planned sale 13 Feb 2025
Value US$86,471.00 | Price 7.86 | Shares 11,000
Planned sale 13 Feb 2025
Value US$82,526.85 | Price 7.86 | Shares 10,500
Proposed sale 13 Feb 2025
Value US$708,827.24 | Price 7.72 | Shares 91,817
Proposed sale 13 Feb 2025
Value US$84,920.00 | Price 7.72 | Shares 11,000
Proposed sale 13 Feb 2025
Value US$23,160.00 | Price 7.72 | Shares 3,000
Proposed sale 13 Feb 2025
Value US$81,060.00 | Price 7.72 | Shares 10,500
Buy 11 Oct 2024
Value US$3,957.65 | Price 7.92 | Shares 500
Buy 17 Jul 2024
Value US$13,540.00 | Price 6.77 | Shares 2,000
Buy 16 Jul 2024
Value US$68,065.00 | Price 6.81 | Shares 10,000
Buy 12 Jul 2024
Value US$58,661.00 | Price 5.87 | Shares 10,000
Buy 6 Sep 2023
Value US$4,959.10 | Price 4.96 | Shares 1,000
Buy 6 Sep 2023
Value US$48,764.00 | Price 4.88 | Shares 10,000
Buy 5 Sep 2023
Value US$2,564.50 | Price 5.13 | Shares 500
Buy 5 Sep 2023
Value US$51,333.00 | Price 5.13 | Shares 10,000
Buy 23 Jun 2023
Value US$1,635.67 | Price 5.95 | Shares 275
Buy 9 Jun 2023
Value US$1,794.00 | Price 5.52 | Shares 325
Buy 30 May 2023
Value US$2,042.12 | Price 5.11 | Shares 400
Buy 18 May 2023
Value US$12,377.55 | Price 5.05 | Shares 2,451
Buy 18 May 2023
Value US$504.50 | Price 5.05 | Shares 100
Buy 18 May 2023
Value US$23,985.36 | Price 5.04 | Shares 4,759
Buy 18 May 2023
Value US$5,039.90 | Price 5.04 | Shares 1,000
Buy 18 May 2023
Value US$1,511.73 | Price 5.04 | Shares 300
Buy 18 May 2023
Value US$6,998.65 | Price 5.04 | Shares 1,390
Buy 18 May 2023
Value US$3,410.21 | Price 4.95 | Shares 689
Buy 18 May 2023
Value US$9,899.80 | Price 4.95 | Shares 2,000
Buy 18 May 2023
Value US$251.94 | Price 4.94 | Shares 51
Buy 17 Mar 2023
Value US$2,502.36 | Price 4.82 | Shares 519
Buy 14 Mar 2023
Value US$9,217.80 | Price 4.61 | Shares 2,000
Buy 10 Mar 2023
Value US$413.50 | Price 4.14 | Shares 100
Buy 10 Mar 2023
Value US$4,553.67 | Price 4.14 | Shares 1,100
Buy 10 Mar 2023
Value US$7,158.75 | Price 4.15 | Shares 1,725
Buy 9 Mar 2023
Value US$46,148.30 | Price 4.20 | Shares 11,000
Buy 9 Mar 2023
Value US$41,978.00 | Price 4.20 | Shares 10,000
Buy 9 Mar 2023
Value US$20,731.50 | Price 4.15 | Shares 5,000
Buy 13 Jan 2023
Value US$139.62 | Price 5.59 | Shares 25
Buy 13 Jan 2023
Value US$3,550.20 | Price 5.82 | Shares 610
Buy 13 Jan 2023
Value US$51,679.05 | Price 5.44 | Shares 9,500
Buy 30 Sep 2022
Value US$2,393.20 | Price 5.98 | Shares 400
Buy 30 Sep 2022
Value US$3,588.00 | Price 5.98 | Shares 600
Buy 25 May 2022
Value US$8,780.00 | Price 4.39 | Shares 2,000
Buy 25 May 2022
Value US$43,900.00 | Price 4.39 | Shares 10,000
Buy 25 May 2022
Value US$4,385.00 | Price 4.39 | Shares 1,000
Buy 25 May 2022
Value US$8,711.00 | Price 4.36 | Shares 2,000
Buy 20 May 2022
Value US$974.00 | Price 4.87 | Shares 200
Buy 18 May 2022
Value US$1,684.83 | Price 4.97 | Shares 339
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-22 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
25,302 +7.6%
442.54
US$4,793,621 		25,302 +7.6% 442.54 US$4,793,621
2026-05-13 2026-05-11 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
90,919 -21.7%
346.28
US$3,062,126 		90,919 -21.7% 346.28 US$3,062,126
2026-05-11 2026-05-11 PrS Proposed sale
Rahsaan Thompson

Officer; Chief Legal & Compliance / Secretary

Officer
63,016
181.52
US$1,606,183 		63,016 181.52 US$1,606,183
2026-03-16 2026-03-16 PrS Proposed sale
3.6
RAYMOND L CLIFTON

Officer

Officer
345,428
9.87
US$3,409,374 		345,428 9.87 US$3,409,374
2026-02-10 2026-02-09 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
14,625 -3.6%
8.56
US$125,186 		14,625 -3.6% 8.56 US$125,186
2026-02-04 2026-02-03 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
3,000 -9.2%
9.18
US$27,548 		3,000 -9.2% 9.18 US$27,548
2026-02-04 2026-02-03 PlS Planned sale
3.3
Schafer Joshua

CCO

Officer
10,500 -14.4%
9.19
US$96,500 		10,500 -14.4% 9.19 US$96,500
2026-02-02 2026-02-02 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
105,625
9.00
US$950,625 		105,625 9.00 US$950,625
2026-02-02 2026-02-02 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
91,000 -20.0%
9.38
US$853,425 		91,000 -20.0% 9.38 US$853,425
2026-02-02 2026-01-30 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
4,080 -7.6%
8.83
US$36,010 		4,080 -7.6% 8.83 US$36,010
2026-02-02 2026-01-30 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
1,750 -7.7%
8.82
US$15,442 		1,750 -7.7% 8.82 US$15,442
2026-02-02 2026-01-30 PlS Planned sale
3.3
Schafer Joshua

CCO

Officer
3,375 -8.3%
8.83
US$29,800 		3,375 -8.3% 8.83 US$29,800
2026-02-02 2026-01-30 PlS Planned sale
Quartel Adrian W

Chief Medical Officer

Officer
4,533 -31.8%
8.83
US$40,036 		4,533 -31.8% 8.83 US$40,036
2026-01-30 2026-01-30 PrS Proposed sale
3.1
TIMOTHY SANGIOVANNI

Officer

Officer
4,750
8.86
US$42,085 		4,750 8.86 US$42,085
2026-01-30 2026-01-30 PrS Proposed sale
3.6
R LaDuane Clifton

Former CFO & Treasurer
14,000
8.86
US$124,040 		14,000 8.86 US$124,040
2026-01-30 2026-01-30 PrS Proposed sale
RAHSAAN THOMPSON

Officer; Secretary

Officer
4,080
8.86
US$36,149 		4,080 8.86 US$36,149
2026-01-30 2026-01-30 PrS Proposed sale
3.3
JOSHUA SCHAFER

Officer

Officer
13,875
8.86
US$122,932 		13,875 8.86 US$122,932
2026-01-30 2026-01-30 PrS Proposed sale
ADRIAN QUARTEL

Officer

Officer
4,533
8.86
US$40,162 		4,533 8.86 US$40,162
2025-10-10 2025-10-10 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
19,500
10.82
US$210,990 		19,500 10.82 US$210,990
2025-10-10 2025-10-10 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
19,500 -8.1%
10.82
US$210,908 		19,500 -8.1% 10.82 US$210,908
2025-09-16 2025-09-12 B Purchase
3.7
FAVORITO TAMARA A
Non-Executive Director
3,175 +441.6%
7.79
US$24,718 		3,175 +441.6% 7.79 US$24,718
2025-09-15 2025-09-12 B Purchase
3.0
Shih Alvin
Non-Executive Director
20,000 +inf%
7.89
US$157,800 		20,000 +inf% 7.89 US$157,800
2025-08-20 2025-08-19 B Purchase
3.4
Bode John B
Non-Executive Director
5,000 +12.5%
9.17
US$45,825 		5,000 +12.5% 9.17 US$45,825
2025-06-30 2025-06-26 PlS Planned sale
Thompson Rahsaan

Chief Legal & Compliance

Officer
24,000 -36.0%
9.21
US$221,004 		24,000 -36.0% 9.21 US$221,004
2025-06-26 2025-06-26 PrS Proposed sale
RAHSAAN THOMPSON

Officer; Secretary

Officer
24,000
9.33
US$223,920 		24,000 9.33 US$223,920
2025-03-31 2025-03-28 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
300 +20.0%
7.84
US$2,352 		300 +20.0% 7.84 US$2,352
2025-03-21 2025-03-19 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +33.3%
7.96
US$79,624 		10,000 +33.3% 7.96 US$79,624
2025-02-14 2025-02-14 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
30,544 -13.8%
8.05
US$245,962 		30,544 -13.8% 8.05 US$245,962
2025-02-14 2025-02-13 PlS Planned sale
3.1
Sangiovanni Timothy J.

SVP, Finance & Corp Controller

Officer
3,000 -15.5%
7.86
US$23,588 		3,000 -15.5% 7.86 US$23,588
2025-02-14 2025-02-13 PlS Planned sale
McFarlane Neil F.

President and CEO

Executive Director
61,273 -21.6%
7.86
US$481,428 		61,273 -21.6% 7.86 US$481,428
2025-02-14 2025-02-13 PlS Planned sale
3.6
Clifton R. LaDuane

CFO & Treasurer

Officer
11,000 -17.6%
7.86
US$86,471 		11,000 -17.6% 7.86 US$86,471
2025-02-14 2025-02-13 PlS Planned sale
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
10,500 -26.3%
7.86
US$82,527 		10,500 -26.3% 7.86 US$82,527
2025-02-13 2025-02-13 PrS Proposed sale
NEIL F MCFARLANE

Director; Officer

Executive Director
91,817
7.72
US$708,827 		91,817 7.72 US$708,827
2025-02-13 2025-02-13 PrS Proposed sale
3.6
R. LADUANE CLIFTON

Officer

Officer
11,000
7.72
US$84,920 		11,000 7.72 US$84,920
2025-02-13 2025-02-13 PrS Proposed sale
3.1
Timothy Sangiovanni

Officer

Officer
3,000
7.72
US$23,160 		3,000 7.72 US$23,160
2025-02-13 2025-02-13 PrS Proposed sale
3.3
Joshua Schafer

Officer

Officer
10,500
7.72
US$81,060 		10,500 7.72 US$81,060
2024-10-16 2024-10-11 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
500 +50.0%
7.92
US$3,958 		500 +50.0% 7.92 US$3,958
2024-07-17 2024-07-17 B Purchase
3.6
Clifton R. LaDuane

CFO & Treasurer

Officer
2,000 +12.1%
6.77
US$13,540 		2,000 +12.1% 6.77 US$13,540
2024-07-16 2024-07-16 B Purchase
3.2
Anderson Thomas
Non-Executive Director
10,000 +100.0%
6.81
US$68,065 		10,000 +100.0% 6.81 US$68,065
2024-07-15 2024-07-12 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +50.0%
5.87
US$58,661 		10,000 +50.0% 5.87 US$58,661
2023-09-06 2023-09-06 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
1,000 +7.0%
4.96
US$4,959 		1,000 +7.0% 4.96 US$4,959
2023-09-06 2023-09-06 B Purchase
3.2
Anderson Thomas
Non-Executive Director
10,000 +inf%
4.88
US$48,764 		10,000 +inf% 4.88 US$48,764
2023-09-06 2023-09-05 B Purchase
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
500 +16.7%
5.13
US$2,564 		500 +16.7% 5.13 US$2,564
2023-09-06 2023-09-05 B Purchase
3.4
Bode John B
Non-Executive Director
10,000 +100.0%
5.13
US$51,333 		10,000 +100.0% 5.13 US$51,333
2023-06-26 2023-06-23 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
275 +37.9%
5.95
US$1,636 		275 +37.9% 5.95 US$1,636
2023-06-13 2023-06-09 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
325 +81.2%
5.52
US$1,794 		325 +81.2% 5.52 US$1,794
2023-05-31 2023-05-30 B Purchase
2.6
Watton Corey Michael
Non-Executive Director
400 +inf%
5.11
US$2,042 		400 +inf% 5.11 US$2,042
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
2,451 +32.5%
5.05
US$12,378 		2,451 +32.5% 5.05 US$12,378
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
100 +1.3%
5.05
US$504 		100 +1.3% 5.05 US$504
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
4,759 +176.9%
5.04
US$23,985 		4,759 +176.9% 5.04 US$23,985
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
1,000 +59.2%
5.04
US$5,040 		1,000 +59.2% 5.04 US$5,040
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
300 +21.6%
5.04
US$1,512 		300 +21.6% 5.04 US$1,512
2023-05-19 2023-05-18 B Purchase
3.4
Bode John B
Non-Executive Director
1,390 +inf%
5.04
US$6,999 		1,390 +inf% 5.04 US$6,999
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
689 +5.3%
4.95
US$3,410 		689 +5.3% 4.95 US$3,410
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
2,000 +18.1%
4.95
US$9,900 		2,000 +18.1% 4.95 US$9,900
2023-05-18 2023-05-18 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
51 +0.5%
4.94
US$252 		51 +0.5% 4.94 US$252
2023-03-21 2023-03-17 B Purchase
3.7
SEYMOUR TAMARA A
Non-Executive Director
519 +259.5%
4.82
US$2,502 		519 +259.5% 4.82 US$2,502
2023-03-15 2023-03-14 B Purchase
3.3
Schafer Joshua

CCO & EVP, Bus. Development

Officer
2,000 +inf%
4.61
US$9,218 		2,000 +inf% 4.61 US$9,218
2023-03-13 2023-03-10 B Purchase
3.1
Sangiovanni Timothy J.

SVP, Corporate Controller

Officer
100 +2.3%
4.14
US$414 		100 +2.3% 4.14 US$414
2023-03-13 2023-03-10 B Purchase
3.1
Sangiovanni Timothy J.

SVP, Corporate Controller

Officer
1,100 +33.9%
4.14
US$4,554 		1,100 +33.9% 4.14 US$4,554
2023-03-13 2023-03-10 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
1,725 +18.6%
4.15
US$7,159 		1,725 +18.6% 4.15 US$7,159
2023-03-13 2023-03-09 B Purchase
3.6
Plooster Matthew R
Non-Executive Director
11,000 +146.7%
4.20
US$46,148 		11,000 +146.7% 4.20 US$46,148
2023-03-13 2023-03-09 B Purchase
3.5
Pascoe Richard W

Chief Executive Officer

Executive Director
10,000 +50.1%
4.20
US$41,978 		10,000 +50.1% 4.20 US$41,978
2023-03-13 2023-03-09 B Purchase
2.9
Tierney David S
Non-Executive Director
5,000 +85.7%
4.15
US$20,732 		5,000 +85.7% 4.15 US$20,732
2023-01-13 2023-01-13 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
25 +0.3%
5.59
US$140 		25 +0.3% 5.59 US$140
2023-01-13 2023-01-13 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
610 +7.1%
5.82
US$3,550 		610 +7.1% 5.82 US$3,550
2023-01-13 2023-01-13 B Purchase
3.5
Pascoe Richard W

Chief Executive Officer

Executive Director
9,500 +90.7%
5.44
US$51,679 		9,500 +90.7% 5.44 US$51,679
2022-10-03 2022-09-30 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
400 +5.2%
5.98
US$2,393 		400 +5.2% 5.98 US$2,393
2022-10-03 2022-09-30 B Purchase
3.6
Clifton R. LaDuane

CFO, Secretary & Treasurer

Officer
600 +8.4%
5.98
US$3,588 		600 +8.4% 5.98 US$3,588
2022-05-26 2022-05-25 B Purchase
2.9
Tierney David S
Non-Executive Director
2,000 +52.2%
4.39
US$8,780 		2,000 +52.2% 4.39 US$8,780
2022-05-25 2022-05-25 B Purchase
3.4
Mickle Travis C

President & CEO

Executive Director
10,000 +967.1%
4.39
US$43,900 		10,000 +967.1% 4.39 US$43,900
2022-05-25 2022-05-25 B Purchase
3.4
Mickle Travis C

President & CEO

Executive Director
1,000 +2.6%
4.39
US$4,385 		1,000 +2.6% 4.39 US$4,385
2022-05-25 2022-05-25 B Purchase
3.4
Mickle Travis C

President & CEO

Executive Director
2,000 +5.5%
4.36
US$8,711 		2,000 +5.5% 4.36 US$8,711
2022-05-24 2022-05-20 B Purchase
3.7
SEYMOUR TAMARA A
Non-Executive Director
200 +inf%
4.87
US$974 		200 +inf% 4.87 US$974
2022-05-18 2022-05-18 B Purchase
3.6
Plooster Matthew R
Non-Executive Director
339 +4.7%
4.97
US$1,685 		339 +4.7% 4.97 US$1,685
Explore more

More insider trading research around Zevra Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America